About Blood Disorders

Blood disorders are characterized by their highly specialized nature, rarity, and need for long-term, advanced therapy. This is an area that requires flexible, multi-tiered responses that go beyond traditional health system, institutional operation, and patient support frameworks. In addition to advances in medical technology, stakeholders like such as academic societies and pharmaceutical companies are making progress with initiatives that actively incorporate the perspectives of people living with blood disorders and other affected parties. To encourage new developments and to share best practices from the area of blood disorders to other disease areas, HGPI launched a policy recommendation project titled “Blood Disorders Measures Promotion Project” in 2024.